The METABRIC data cohort identified a significant correlation between overexpression of CD44/ALDH1A1 and HSP90 or HSF1 in patients with HER2-positive breast cancer, which was associated with relatively poorer overall survival. This evidence concerns the gene CD44 and breast carcinoma.